Robert Wasserman
Stock Analyst at Benchmark Co.
(4.15)
# 1,531
Out of 4,572 analysts
230
Total ratings
45.2%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,610 | ILA 2,160 | +113.42% | 5 | Jul 20, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 → $335 | $300.53 | +11.47% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $131.96 | +40.19% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Maintained: Buy | $91 | $78.24 | +16.31% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $71.60 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $98.62 | -3.67% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $81.93 | +9.85% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Maintained: Hold | n/a | $1.48 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $2.03 | +97.04% | 11 | Nov 6, 2025 | |
| INTS Intensity Therapeutics | Maintained: Buy | $38 | $4.45 | +742.70% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.31 | - | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $3.64 | +37.36% | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $29.98 | +0.07% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $7.26 | +65.29% | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.36 | +120.59% | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $4.54 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $568.26 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $191.50 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.13 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.60 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.34 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.18 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.382 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $1.45 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $2.05 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.33 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $1.05 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $5.98 | n/a | 1 | Mar 12, 2013 |
Kamada Ltd.
Jul 20, 2026
Maintained: Buy
Price Target: ILA 4,610
Current: ILA 2,160
Upside: +113.42%
Ligand Pharmaceuticals
Jul 16, 2026
Maintained: Buy
Price Target: $220 → $335
Current: $300.53
Upside: +11.47%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $131.96
Upside: +40.19%
Proto Labs
Jul 6, 2026
Maintained: Buy
Price Target: $91
Current: $78.24
Upside: +16.31%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $71.60
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $98.62
Upside: -3.67%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $81.93
Upside: +9.85%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $1.48
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $2.03
Upside: +97.04%
Intensity Therapeutics
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $4.45
Upside: +742.70%
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $5.31
Upside: -
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $3.64
Upside: +37.36%
Aug 11, 2025
Maintained: Buy
Price Target: $30
Current: $29.98
Upside: +0.07%
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $7.26
Upside: +65.29%
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.36
Upside: +120.59%
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $4.54
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $568.26
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $191.50
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $6.13
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.60
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $3.34
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.18
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.382
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $1.45
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $2.05
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.33
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $1.05
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $5.98
Upside: n/a